NEW WESTMINSTER, BC, March 12, 2020 /CNW/ - Amid growing concerns about the spread of the novel coronavirus COVID-19, and the need to take constructive steps to control contamination, the Board of Directors of Health Sciences Association of BC (HSA) has postponed indefinitely the union's annual convention, slated for April 1-3, 2020 at the Hyatt Regency Hotel in Vancouver.
"This was a difficult call, but the right call for a union whose members are on the front lines of delivering care, as well as at risk to exposure," said HSA President Val Avery.
HSA represents many of the specialized health professionals who make up the health care team, including registered respiratory therapists and physiotherapists who are key to treating patients with respiratory infection and disease. The union also represents the health care providers responsible for diagnosis and recovery of patients.
"HSA's convention brings together upwards of 400 health professionals who are critical to the good health of British Columbians. Bringing them together at a time when what has now been confirmed as a global pandemic is on the rise, is just too risky for our members, and the general public they serve," Avery said.
HSA has been involved in regular briefings with the Ministry of Health, Deputy Provincial Health Officer Bonnie Henry, health employers, and other health care unions since January.
"We have been monitoring events closely. The situation is changing daily, and our priority must be to preserve the integrity of our public health care system by reducing risks to the health care workers British Columbians rely on for their good health," Avery said.
SOURCE Health Sciences Association of British Columbia
Vaping chemical creates toxic ketene gas, RCSI research
Researchers warn that vaping can cause health-damaging chemical reactions
DUBLIN, March 11, 2020 – A chemical found in some vaping products can produce a highly toxic gas when heated up, according to new research from RCSI University of Medicine and Health Sciences.
Led by researchers at RCSI’s Department of Chemistry, the study is published in the current edition of PNAS.
In August 2019, the US Centers for Disease Control and Prevention reported an increasing number of lung injuries following the use of some vaping products, and vitamin E acetate was identified as one possible cause. Though some patient lung biopsies showed signs of chemical burns that vitamin E acetate alone would not be expected to cause.
Vitamin E acetate, primarily found in illegally made THC-based vape liquids, is considered non-toxic in vitamin supplements and skin creams. This new research has now shown that heating up vitamin E acetate through vaping can produce ketene, a highly toxic gas.
Ketene is a colourless gas with a penetrating odour. When inhaled, it can cause serious damage to the lungs up to 24 hours after exposure. It is lethal at high concentrations, and at lower concentrations, it can irritate the eyes and lungs and impair the central nervous system.
The researchers connected a vaping device to a series of glass vessels, which allowed them to collect samples after simulating a person vaping vitamin E acetate from the device.
In addition to chemically trapping the toxic ketene gas, the researchers also found that heating up vitamin E acetate produces other carcinogens that are found in regular tobacco smoke.
“It should be noted, however, that these experiments were designed to determine the vaping effect on a single pure substance at the chemistry molecular level. Determining the exact relevance of these results to the direct cause of lung injury requires further studies due to the diversity in vaping devices, mixtures and their modes of use,” said the study’s lead author and RCSI Professor of Chemistry Donal O’Shea.
While vitamin E acetate is typically found in illicit street-bought vapes, the researchers warned against the potential dangers of the ever growing number of chemicals found in vaping products.
“The high temperatures created in vaping devices can lead to unforeseen chemical reactions. Therefore, other components of vape mixtures, including flavours and additives, also require investigation as they too may produce toxic and carcinogenic substances when heated,” said Professor O’Shea.
RCSI University of Medicine and Health Sciences is ranked among the top 250 (top 2%) of universities worldwide in the Times Higher Education World University Rankings (2020) and its research is ranked first in Ireland for citations. It is an international not-for-profit university, with its headquarters in Dublin, focused on education and research to drive improvements in human health worldwide. RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.
Canopy Growth and TerrAscend Canada Enter Debt Financing Arrangement
Canopy Growth completes C$80.5 million loan to TerrAscend Canada Inc.
SMITHS FALLS, ON, March 11, 2020 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NYSE:CGC) and TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly owned subsidiary of TerrAscend Corp. ("TerrAscend") (CSE:TER, OTCQX: TRSSF), today announced they have entered into a loan financing arrangement in the amount of C$80.5 million (the "Loan") pursuant to a secured debenture (the "Debenture"). In connection with the Loan, TerrAscend has issued 17,808,975 common share purchase warrants to the Company (the "Warrants").
Canopy Growth initially co-invested in TerrAscend in November 2017. On November 30, 2018, Canopy Growth announced the completion of a restructuring transaction with TerrAscend pursuant to which TerrAscend restructured its share capital by way of a plan of arrangement under the Business Corporations Act (Ontario).
"TerrAscend Canada has proven its ability to thrive and this loan is a strong signal that Canopy Growth is confident in their ability to execute over the long term," said David Klein, CEO, Canopy Growth. "We are encouraged by TerrAscend's strong performance and we view the team's experience as an important contributor to its continued success."
"We are pleased to receive this loan from Canopy Growth as we enter into the next stage of TerrAscend's growth and expansion," said Jason Ackerman, Executive Chairman and Interim CEO. "We look forward to continuing to work with Canopy Growth as new opportunities emerge and the regulatory landscape evolves."
Use of Proceeds
The net proceeds are expected to be used by TerrAscend Canada for general corporate purposes and the funding of its Canadian operations, its Arise Bioscience U.S. hemp division, international expansion and the repayment of indebtedness. The funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States.
Transaction Overview
The Debenture will bear interest at a rate of 6.10% per annum and will mature on March 10, 2030 or such earlier date in accordance with the terms of the Debenture and all interest payments made pursuant to the Debenture are payable in cash by TerrAscend Canada. The Debenture is secured by the assets of TerrAscend Canada, is not convertible and is not guaranteed by TerrAscend. The Warrants are comprised of 15,656,242 common share purchase warrants (the "First Tranche Warrants") with each First Tranche Warrant entitling Canopy Growth to acquire one common share of TerrAscend at an exercise price of $5.14 per share, subject to adjustment in certain events and 2,152,733 common share purchase warrants (the "Second Tranche Warrants") with each Second Tranche Warrant entitling Canopy Growth to acquire one common share of TerrAscend at an exercise price of $3.74 per share, subject to adjustments in certain events. The Warrants will be exercisable by Canopy Growth following changes in U.S. federal laws permitting the cultivation, distribution and possession of marijuana or to remove the regulation of such activities from the federal laws of the United States. The First Tranche Warrants expire on March 10, 2030 or such earlier date in accordance with the First Tranche Warrants and the Second Tranche Warrants expire on March 10, 2031 or such earlier date in accordance with the Second Tranche Warrants.
About Canopy Growth Corporation Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.
Canopy Growth's medical division, Spectrum Therapeutics, is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting-edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements include statements with respect to the use of proceeds, management's belief of TerrAscend's ability over the long term and the expectation that the Loan will enable TerrAscend to fund and execute on its Canadian, U.S. hemp and international businesses. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including regulatory and licensing risks, the ability of the Company to exercise the Warrants and the occurrence of changes in U.S. federal laws regarding the cultivation, distribution or possession of marijuana, changes in the use of proceeds, changes in general economic, business and political conditions, including changes in the financial and stock markets, the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change, risks relating to anti-money laundering laws, compliance with extensive government regulation and the interpretation of various laws, regulations and policies, risk associated with divesting certain of investments, public opinion and perception of the cannabis industry, and such risks contained in the public filings of the Company filed with Canadian securities regulators and available on the issuer profile of the Company on SEDAR at www.sedar.com, including the Company's annual information form dated June 25, 2019. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.
SOURCE Canopy Growth Corporation
AbbVie Announces New Formulary Listings for SKYRIZI® in the Treatment of Moderate to Severe Plaque Psoriasis
SKYRIZI® is an interleukin-23 (IL-23) inhibitor used for the treatment of moderate to severe psoriasis.1
In clinical studies, SKYRIZI® significantly improved levels of skin clearance after just 16 weeks and maintained clearance at one year (52 weeks).1
Non-Insured Health Benefits program lists SKYRIZI® on its formulary effective February 21, 2020.
Manitoba lists SKYRIZI® on its provincial formulary effective March 02, 2020.
SKYRIZI® is the only IL-23 inhibitor to arrive at a positive conclusion with the pCPA and is currently listed on the formularies of Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nova Scotia and the Non-Insured Health Benefits program.
MONTRÉAL, March 11, 2020 /CNW/ - AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced today that SKYRIZI® (risankizumab) is now listed on the formularies of the Non-Insured Health Benefits program (NIHB) and the province of Manitoba for the treatment of moderate to severe plaque psoriasis. This announcement comes just three months after AbbVie successfully reached an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA), bringing a much-needed treatment to patients living with psoriasis.
Psoriasis is a chronic condition affecting 125 million people worldwide, including 1 million Canadians, and many patients despite treatment still do not reach their goals or lose treatment response over time.2-4 The most common form is plaque psoriasis, which affects approximately 90% of patients. 5
SKYRIZI® (risankizumab) is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.
"It's been very rewarding to see my psoriasis patients on the biologic SKYRIZI® respond so favorably. In my patients, I witness both a durable skin response and an improvement in quality of life and well-being," states Dr. Marni C. Wiseman MD FRCPC, Dermatologist from SKiNWISE DERMATOLOGY. "There currently is a need for treatments with longer dosing intervals for patients located in remote communities. I am so pleased that Manitobans and Canada's Indigenous population will have better access to this treatment," adds Dr. Wiseman.
According to the 2016 census, Aboriginal peoples in Canada totaled 1,673,785 people, or 4.9% of the national population.6 Of these, 223,310 Aboriginal people live in Manitoba, making up 18.0% of that population.7
For the Non-Insured Health Benefits program (NIHB), SKYRIZI® is effectively listed on NIHB's Limited Use formulary as of February 21, 2020 and criteria details will be featured in their next bulletin update.
Information regarding the Manitoba provincial criteria may be found by consulting the following link:
About SKYRIZI® SKYRIZI® is a novel, humanized immunoglobulin monoclonal antibody designed to selectively inhibit IL-23, a naturally occurring cytokine involved in inflammatory and immune responses.1 On April 17, 2019, SKYRIZI™ received a NOC from Health Canada for the treatment of moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy, based on results from clinical studies showing significant improvement in levels of skin clearance after just 16 weeks and at 52 weeks with every 3-month dosing in more than 2000 adult patients.1 Four pivotal Phase 3 studies, ultIMMa-1, ultIMMa-2, IMMvent and IMMhance evaluated more than 2,000 patients with moderate to severe plaque psoriasis.4 Canadians living with moderate to severe plaque psoriasis were well represented in all four of the pivotal clinical trials leading to Health Canada's approval, showing the Canadian leadership in this clinical development program.
About AbbVie Care The AbbVie Care program is designed to provide a wide range of customized services including reimbursement and financial support, pharmacy services, lab work reminders and coordination, personalized education and ongoing disease management support throughout the treatment journey. For more information, consult www.abbviecare.ca.
About AbbVie AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.ca and www.abbvie.com. Follow @abbvieCanada and @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
References:
1.
SKYRIZI® (risankizumab) [Canadian Product Monograph]. AbbVie Corporation, April 17, 2019.
Award-Winning Parma! Vegan Parmesan Offers Cheese Lovers A Delectably Nutritious Range of Dairy-Free, Protein-Rich Condiments Ideal For Main Dishes, Salads, Pizza & More!
Parma! Debuts Bold New Website As Company Continues Major Expansion
MEDFORD, OREGON, MARCH 11, 2020 - With just the right condiment, a plain salad becomes a festival of flavors, a plate of vegetables transforms into a delectable stroll through a country garden, and an ordinary bowl of pasta becomes a savory work of art. And perhaps no condiment covers as many different foods and as many different cultures as classic Italian Parmesan cheese.
Unfortunately, for vegans or anyone following a dairy-free and/or calorie-conscious diet, parmesan cheese has always been not only off limits but one of the most difficult of life’s little indulgences to forego. If only someone, somewhere, could create a non-dairy parmesan cheese alternative so authentically delectable that even the most discerning cheese lovers would never miss its conventional counterpart ever again!
Well, luckily for countless millions of us, someone has. Welcome to the next revolution within the booming vegan cheese category – Parma!
Created in Oregon just over 15 years ago by Sister River Foods’ founder Shannon Schnibbe (with Tofurky founder Seth Tibbott as an ongoing Advisor), Parma! was established in response to a rapidly-growing need within the vegetarian marketplace for a breakthrough allergen-free parmesan alternative.
Comprised of four deliciously distinct varieties – including Better Than Bacon Parma! –voted Favorite Bacon-Flavored Product in 2017 by VegNews magazine – Parma! is a plant-based umami superfood line of convenient and affordable products that are Paleo and Keto-friendly, a complete protein, dairy-free, soy-free, gluten-free, non-GMO and Certified Kosher.
In addition, all four raw nut and seed-based Parma! flavors contain whole raw ingredients, are low in sodium, heart-healthy, packed with essential B vitamins and trace minerals, replete with beneficial animo acids and an excellent source of healthy oils.
Enjoying its most successful period of growth to date in terms of both distribution and revenue, Parma! this week introduces an ambitious new website featuring easy navigation, boldly colorful images and graphics, exciting new recipes and convenient shopping options.
Bringing Italy A Whole Lot Closer
Available in health stores nationwide as well as on the brand new www.eatparma.com site, Amazon, VitaCost and other online retailers, Parma! is ideal for environmentally conscious consumers, vegans, vegetarians, flexitarians and all health conscious eaters. Unlike some other vegan cheese alternatives, Parma! has also proven highly appealing to mainstream cheese aficionados who are ready to eschew traditional cheese so long as a healthier option boasting authentic flavor, aroma and texture is available.
Sold in 3.5 and 7-ounce bottles, Parma! can be savored on pasta, lightly steamed vegetables, pizza, salads, potatoes, avocado toast, popcorn and countless other hor d'oeuvres, main dishes and desserts. For suggested recipes, please visit https://eatparma.com/category/recipes/.
Parma! varieties include:
Original Parma! – Featuring an irresistiblycheesey umami flavor. Ingredients: Nutritional Yeast, Organic SunflowerSeeds, Walnuts, Himalayan Crystal Salt, Organic Hemp Seeds.
Better Than Bacon Parma! – Voted Favorite Bacon FlavoredProduct by VegNews and featuring a smokey cheesey umami bacon flavor. Ingredients: Nutritional Yeast, Organic Sunflower Seeds, Walnuts, Ground Paprika, Organic Dried Onion, Natural Flavor, Organic Brown Sugar, Himalayan Crystal Salt, Smoked Salt, Organic Hemp Seeds.
Chipotle Cayenne Parma! – Blessed with a smokey umami flavor akin to the most popular barbeque potato chips, with a slight cayenne kick at the end. Ingredients: Nutritional Yeast, Organic SunflowerSeeds, Walnuts, Organic Ground Chipotle Pepper, Himalayan Crystal Salt, Organic Hemp Seeds, Organic Onion Powder, Organic Ground Cayenne Pepper.
Garlicky Green Parma! – Distinguished by acheesey umami Italian herb flavour complemented by nutritiously delicious kelp, pumpkin and sesame seeds. Ingredients: Nutritional Yeast, Organic SunflowerSeeds, Walnuts, Organic Pumpkin Seeds, OrganicDried Garlic, Himalayan Crystal Salt, Organic Hemp Seeds, Organic Sesame Seeds, Organic Kelp Powder, Organic Dried Basil, Organic Dried Oregano.
For parmesan lovers in Europe (in other words – just about everyone!), Parma! also offers a specially branded line called Shake! Original featuring a mouth-wateringly cheesey umami flavor and such ingredients as nutritional yeast, raw organic sunflower seeds, raw walnuts, raw organic pumpkin seeds, raw organic hemp seeds, and Himalayan crystal salt.
Parma! is expected to introduce a bold new line of products to the U.S. marketplace later this year.
Only The Beginning
Founded in 2004, Parma! has steadily grown to its current status as a leader in the dairy-free cheese alternative arena and a key player in the multi-billion-dollar global vegan food category.
Looking back on the origins of the Parma! brand, Sister River Foods’ co-founder and CEO Shannon Schnibbe recalls that it all started as the result of her severe allergies and effort to find foods that might give her relief. Introduced to raw foods, she was soon inspired to begin making what is now Parma! for herself, friends and family. After moving to Oregon and becoming pregnant with her first baby, she decided to combine her passion for healthy eating with her corporate experience and turn her hobby into an actual business. The vegan parmesan revolution had begun!
Today, Shannon takes special pride not only in the rave reviews, industry honors, new distribution channels and increased sales Parma! has enjoyed in recent years, but in her brand’s ability to provide a more nutritious yet equally delicious alternative for those who have been missing out on one of life’s true culinary pleasures – parmesan cheese.
According to Tofurky founder Seth Tibbott, "Like Tofurky, Parma is an authentic, trailblazing brand with deep roots that took hold when the plant-based world was very young. I love that it is a family owned business run by kind, passionate people producing a wholesome vegan food with exceptional flavor."
Adds Shannon, “Parma! gives you that cheesey flavor without all the dairy baggage. It provides an excellent food source of high-quality vitamins and minerals, including B vitamins, omega 3’s and trace minerals, along with the natural goodness of hemp, and it tastes great! We’re deeply grateful for the exceptionally warm reception our brand has received from consumers and industry leaders since our very first days on the market and look forward to continuing to shake up the dairy-free industry for many, many years to come.”
###
In these uncertain times, The Stanford Inn and Resort provides a sanctuary from Urban areas and offers customized resources to enhance one's immunity and general well being
At this quiet haven graced with clean ocean air, the Pacific, and redwood forests, guests learn to cook plant-based meals, use nutrition to enhance immunity, and discover inner calm to build long-term healthy living habits – All just north of the San Francisco Bay MENDOCINO, CA /March 10, 2020 _The Stanford Inn and Resort, is offering travelers a chance to escape their constant concern regarding the coronavirus and focus instead on what they can do - boost their immunity. ”Our immune systems reflect our mental state and overall health, explains Jeff Stanford, who with his wife, Joan, own the Inn.. “We think of the immune system as a gauge to well-being,” “This getaway is a unique opportunity at a crucial time. We’re told the virus doesn’t affect all demographics equally and seniors, particularly those with other health issues, tend to be the most vulnerable,” said Sid Garza-Hillman, the Wellness Programs Director and Certified Nutritionist. Garza-Hillman is the author of Approaching the Natural: A Health Manifesto. “While it’s always the right time to adopt healthy habits, moments like these really stress the importance of taking charge of your health and stress and we’ve been teaching people how to successfully do this for decades.” Sid teaches the whole food, plant-based, cooking and nutrition workshops in which guests don aprons and use fresh produce from the resort’s GROW BIOINTENSIVE® educational farm. Joan Stanford, a Registered Art Therapist offers a creative play workshop. She adds, “When we’re engaged in creative activities our brains exhibit patterns seen in the brains of children at play. We all benefit from expressing ourselves creatively – experiencing less stress and more joy, boosting wellbeing.” The experience are truly rejuvenating. Jeff, a meditator since he was 18, discusses a practical and doable approach to meditation which destresses while at the same time encourages self-knowing. An iconoclast he believes that we were born to meditate and that many techniques increase rather than relieve stress. “Meditation is easy and leads to insight, self-knowledge, and beyond. It’s not a chore, it is fun and lightens our load.” Those who’ve been considering changing habits but feel overwhelmed will find compassionate guidance at the Stanford Inn and Resort. ”Creating a new habit is a process and can be overwhelming and ineffective if not done correctly,” Sid explains. “We’re here to help each guest with their individual goals and give them the tools to make long-term, permanent improvements to their lives. We encourage and demonstrate actual lifestyle changes, not quick-fixes.” The skills and techniques guests take home are manageable and sustainable. The information is science-based. The Immune System Boost vacation package is available as an add-on to a three-night minimum stay any time of year! The classes/sessions are taught at the resort over the course of the three days with plenty of down-time to play and explore the breathtaking Mendocino coast, wander the resort’s vast property and or head out on one of the resort’s redwood outrigger canoes; pets are welcome. In fact, the resort has created the only specifically-designed doggie-and-me canoe. The Immune System Boost vacation package includes:A customized Boost Your Immune System Cooking Class (please let us know particular health conditions in advance)Personalized Art & Creativity ClassHealthy Living Class/Nutrition ClassAn exploration of the process of meditation for health and developing a sustainable health-promoting mindset.Boosting Immune System Through Healthy Habits ClassA newsletter including discussions of meditation and health issuesCopy of Sid Garza-Hillman’s books - Raising Healthy Parents: Small Steps, Less Stress, and aThriving Family & Approaching the Natural: A Health ManifestoCopy of The Art of Play: Ignite Your Imagination to Unlock Insight, Healing, and Joy by Joan StanfordThree DinnersThis add-on package costs $775/couple + tax (call for single guest pricing). Taxes, gratuities and lodging are additional; a minimum 3-night stay is required. This package is subject to availability; please contact the Stanford Inn and Resort to verify your dates before making your reservation. About Stanford Inn and ResortNestled atop a meadow that overlooks Mendocino Bay, The Stanford Inn and Resort is a luxurious and sustainable destination providing recreation opportunities from nature tours to yoga, and canoeing and kayaking to massage. AAA Four Diamond rated, family owned and operated, the Resort is unique and a great base for exploring the Mendocino Coast while guests may never leave the property, which offers an indoor saltwater pool, full bar, magnificent gardens, award-winning restaurant, and extensive wellness experiences. In addition to being home to a one of a kind Wellness Center with Chinese medicine, nutrition and cooking classes, Massage in the Forest, creative play shops, and various exercise and meditation options, the Inn features a USDA Organic certified farm which provides produce for the Resort’s Ravens Restaurant. The award-winning restaurant serves organic plant-based cuisine that is conscientiously prepared with respect for the land. Family-friendly and pet-friendly, the Stanford Inn Resort offers an array of life-enhancing experiences. All rooms bask in the glow of warm pine, complete with wood-burning fireplaces and private baths. The Resort is also the site of a GROW BIOINTENSIVE® educational farm, attracting students from around the globe to learn how to sustainably grow a complete diet in the smallest amount of space possible. The Resort also hosts the Environmental Leadership Field School, an intensive hands-on and classroom experience that mobilizes future leaders from different fields to support and enhance the environment, biodiversity, and equitable relationships. Stanford Inn and Resort is located at 44850 Comptche Ukiah Road, POB 487, Mendocino, CA 95460; on Facebook at facebook.com/stanford.inn.mendocino.
Patients in the 'Fight for Our Lives' call on Parliament to STOP the PMPRB!
As the world comes together to fight coronavirus, Canadians with life-threatening rare and common diseases are marching on Parliament Hill to ask for the same support in the Fight for Our Lives.
OTTAWA, March 10, 2020 /CNW/ - The Canadian Organization for Rare Disorders (CORD) is leading a contingent of Canadian patients with rare and common diseases to Parliament Hill at noon today to deliver one common message to their Members of Parliament: "Stop the PMPRB!". The Patented Medicine Prices Review Board (PMPRB) is the single biggest threat to Canadian access to lifesaving and life-altering new medicines.
These new medicines are not just incremental improvements but revolutionary therapies that can cure cancer, restore eyesight, grow new bones, prevent heart attacks and kidney failure, replace blood cells, and repair and replace faulty genes. Some are already funded and available in other countries. But availability to Canadian patients is seriously at risk as companies evaluate the impact of the proposed PMPRB pricing restrictions.
The historic roles of the PMPRB are to ensure drug prices are not "excessive" and to promote research investment by the pharmaceutical industry. The review board has abandoned its mandate on research investment and is extending its role on price control. It is proposing a single standard pricing index for all new medicines, regardless of the severity of the condition or the unmet need. This arbitrary pricing index, which is not supported by any scientific evidence, expert economist, or any other country, proposes to drive Canadian drug prices from 40% to 90% below list price. According to many companies, this level of pricing would be far below the costs of research, development and production. One Canadian executive characterized the dilemma this way: "It would be impossible for us to make the case to launch new medicines in Canada at the same price that we offer to low income countries."
The threat of draconian price restrictions has already stopped some new treatments from coming to Canada. In the past year, companies have delayed or withdrawn submissions for more than a half-dozen innovative therapies and an equal number of submissions for extended or pediatric indications have been quietly cancelled. Even worse, companies have also withdrawn clinical trials from Canada, explaining that if drugs will not be launched here, they cannot ethically start patients through clinical trials. In 2019, the number of clinical trials started in Canada declined by 40% compared to 2018. Similarly, Canadian patients may be denied enrollment in clinical trials in the USA or elsewhere if continued access in Canada is unlikely.
"The inability to access clinical trials is literally a death sentence for patients with life-threatening or progressive diseases with no other effective treatments. Clinical trials have also helped to prepare clinicians and facilities to administer these therapies as soon as they are approved, saving many more lives," said Durhane Wong-Rieger, President & CEO of CORD. "The PMPRB dismisses our concerns as "fear mongering", claiming that companies will not withdraw from Canada. But the exodus already started when the PMPRB issued its draft proposal for new guidelines a year-and-a-half ago."
Example of Cystic fibrosis
The first treatment (Kalydeco) for cystic fibrosis (CF), a genetic progressive lung disease that is usually fatal to children by their teens and early adulthood, was approved in Canada in 2012. But it is effective for only a very small percentage of CF patients with a specific genetic mutation.
Improved therapies have been developed and two of these have been approved in Canada (with limited public funding for one therapy). However, the company that makes the most important new therapy (Trikafta) that could be effective for up to 80% of CF patients has concluded that it cannot afford to submit the drug for approval in Canada in the immediate future.
A 23-year-old Halifax woman with CF, Chantelle Lindsay, died on February 19, 2020, after not being able to access Trikafta, which her medical team said was her final hope.1
"The federal drug price controls are a death sentence for many patients," said Chris McLeod, Chair of the Canadian Cystic Fibrosis Treatment Society and a CF patient who credits Kalydeco for his being alive and fully employed today. "The tragic recent passing of Chantelle Lindsay should be a wake-up call for politicians. Canadians are dying because new life-saving medicines are not coming."
Example of Sickle cell disease
Sickle cell disease (SCD) is an inherited illness in which rigid, crescent-shaped and sticky red blood cells slow or block the flow of blood and oxygen throughout the body, resulting in extreme anemia and debilitating pain crises that can require medication and hospitalization. Recently, the Food and Drug Administration approved the first ever therapies for SCD, Adakveo and Oxbryta, which, respectively, prevent pain crises and red blood cell deformation. Neither treatment has been submitted to Health Canada and there are no immediate plans to file for approval.
"For decades, there have been no effective treatments for sickle cell disease. We now have a revolutionary new drug that can prevent the root cause of the disease, but it won't be made available to Canadians any time soon," said Biba Tinga, President and Executive Director of the Sickle Cell Disease Association of Canada.
"Canadians cannot live with only cheaper old drugs. We deserve access to the truly amazing life-saving and life-altering treatments," said Durhane Wong-Rieger, President & CEO of CORD. "We support fair drug prices in Canada, but not arbitrary restrictive prices that make it impossible to get new treatments here. We call on Members of Parliament to "Stop the PMPRB and stop the harm to patients."
About the Canadian Organization for Rare Disorders (CORD)
CORD is Canada's national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders. CORD works with governments, researchers, clinicians and industry to promote research, diagnosis, treatment and services for all rare disorders in Canada. For more information on CORD, visit: www.raredisorders.ca
SOURCE CANADIAN ORGANIZATION FOR RARE DISORDERS (CORD)
Drake’s Organic Spirits Expands to Sunshine State
Leading distiller of organic spirits added to shelves at BJ’s Wholesale Clubs throughout Florida
Minneapolis, MN (March 10,2020 ) – Drake’s Organic Spirits announced today that its popular Spiked Ice freeze-and-eat adult pops and all-organic Bloody Mary combo packs will soon be available at 33 BJ’s Wholesale Club locations throughout Florida.
“We’re beyond thrilled to be part of the BJ Wholesale Club family,” said Drake’s Founder and CEO Mark Anderson. “BJ’s recognizes that the organic food and drink movement is booming. Consumers want cleaner options for their bodies and they want products that are friendlier to the planet. Drake’s accomplishes both.”
BJ’s Wholesale Club a leading operator of membership warehouse clubs in the Eastern United States.
The chain offers members discounted prices on fresh items, sundries, paper goods, apparel, seasonal items, TVs, electronics, gasoline and much more.
The chain offers members discounted prices on fresh items, sundries, paper goods, apparel, seasonal items, TVs, electronics, gasoline and much more.
Drake’s Organic Spiked Iceä are handheld ice pops that feature 15% ABV and only 80 calories each. Spiked Ice comes in four flavors - Mango Rum Punch, Vodka Lemonade, Watermelon Martini and Classic Mojito - and are made with Drake’s award-winning all-organic ultra-premium vodka and white rum.
Drake’s Bloody Mary Combo Packs feature one (1) liter Drake’s Organic Vodka and one (1) liter of Drake’s Organic Bloody Mary Mixer.
Drake’s Organic Spirits is the first and only spirit line in the world to be certified USDA organic, non-GMO Project Verified, gluten-free, vegan and kosher. The five certifications ensure a cleaner drinking option that comes only from the highest quality organic ingredients. Drake’s continues to be among the most environmentally conscious brands in the spirits industry and deeply committed to using ingredients and processes that lead to a more sustainable planet.
In 2019, Drake’s Organic Premium Vodka was awarded Double Gold and Drake’s Organic White Rum received Gold at the Wine & Spirits Wholesalers of America (WSWA) Convention & Exposition in Orlando, FL. The highly-respected awards are widely considered among the most prestigious in the industry because judges are industry experts who blind taste-test each spirit.
Proceeds from the sale of all Drake’s Organic Spirits products help fund Long Lake Animal Rescue, an animal rescue foundation that takes in animals in urgent need of a second chance at life.
About Drake’s Organic Spirits Minneapolis-based Drake’s Organic Spirits was launched in 2017. Drake’s uses the highest quality USDA organic and non-GMO Project Verified ingredients to create a line of ultra- premium spirits. Drake’s Organic Vodka, Drake’s Organic White Rum and Drakes Organic Spiced Rum offer a no-grain, no-gluten, no-gmo, ultra-premium and 12-times distilled handcrafted spirits at a better price than the leading premium brands.
About BJ's Wholesale Club, Inc. Headquartered in Westborough, Massachusetts, BJ's is a leading operator of membership warehouse clubs in the Eastern United States. The company currently operates 219 clubs and 144 BJ's Gas® locations in 17 states.
Sleep Country Canada celebrates World Sleep Day on March 13 with national giveaway
Canada's sleep experts to give away nap sacs to Canadians, reinforcing the importance of sleep
TORONTO, March 10, 2020 /CNW/ - Sleep Country Canada Holdings Inc. ("Sleep Country" or "Sleep Country Canada" or the "Company") (TSX: ZZZ), is proud to celebrate and be a sponsor of World Sleep Day 2020 in Canada on March 13. The annual event was created to raise awareness about the importance of sleep with a call to action on establishing healthy sleep habits.
"For more than 25 years we've been dedicated to helping Canadians achieve their best sleep," said Christine Magee, Co-Founder & Chair of Sleep Country. "There are many factors that impact a good night's sleep, from your mood and stress level to the number of sleeping hours to finding the right products to suit your sleep style. We're seeing attitudes towards sleep change for the better and initiatives like World Sleep Day are reminders to invest in personal health and well-being, as we continue to work towards better sleep for all."
World Sleep Day aims to raise awareness of the importance of sleep and while Canadians recognize it is a priority, many don't get the benefit of a good night's sleep. Last year, 75 per cent of Canadian respondents to a Maru/Blue survey told Sleep Country Canada that they consider sleep as an important aspect when thinking about health and wellness. Yet, the Public Health Agency of Canada has found that one in two adults have trouble going to sleep or staying asleep, and one in five adults do not find their sleep refreshing.
Sleep Country is committed to All for Sleep. Along with offering Canadians a full line of innovative sleep products and one-on-one access to trained sleep experts, available at 276 locations across the country, Sleep Country has compiled a list of helpful sleep tips to help Canadian's get their best sleep:
Practice relaxation, mindfulness-based stress reduction techniques and meditation before sleep (Public Health Agency of Canada)
Stick to a sleep schedule of the same bedtime and wake up time, even on the weekends. This helps to regulate your body's clock and could help you fall asleep and stay asleep for the night. (SleepFoundation.org)
Practice a relaxing bedtime ritual. A relaxing, routine activity right before bedtime conducted away from bright lights helps separate your sleep time from activities that can cause excitement, stress or anxiety which can make it more difficult to fall asleep, get sound and deep sleep, or remain asleep. (SleepFoundation.org)
Avoid electronics before bed or in the middle of the night. (SleepFoundation.org)
Sleep on a comfortable mattress and pillow. Make sure your mattress is comfortable and supportive. The one you have been using for years may have exceeded its life expectancy. (SleepFoundation.org)
World Sleep Day – All for Sleep Giveaway To celebrate World Sleep Day in Canada, Sleep Country Canada is giving away nap sacs to 100 lucky winners, to help ensure Canadians are equipped for a good night sleep. The prize pack includes a Queen-size reversible comforter, one sheet set (fitted, flat and pillowcase) and pillow packed inside a high-quality reusable bag. Entrants can visit @sleepcountrycan on Instagram from March 13th to 15th to enter. For more information and full contest details visit Sleep Country Canada on Instagram at @sleepcountrycan
About Sleep Country Sleep Country is Canada's leading omnichannel mattress and bedding retailer and the only specialty sleep products retailer with a national bricks and mortar footprint and an online presence. Sleep Country operates under three retail banners (the "Banners"): "Sleep Country Canada", with omnichannel operations in Canada excluding Québec; "Dormez-vous?" with omnichannel operations in Québec and "Endy", Canada's leading online mattress-in-a-box retailer. As of March 10, 2020, Sleep Country has 276 stores and 17 distribution centres across Canada. All of the Company's stores are corporate-owned, enabling it to develop and maintain a strong culture of customer service, resulting in a consistent and superior in-store and home delivery experience. Sleep Country also works closely with Canadian charities to donate new and gently used mattresses to families and children in need.
SOURCE Sleep Country Canada Holdings Inc. Investor Relations
Startup competition returns to recognize top innovators in Canada's technology and aging sector
Winners will receive $20,000 in cash plus in-kind prizes
TORONTO, March 10, 2020 /CNW/ - Are you an entrepreneur or startup with a technology-based solution that can support the health and quality of life of seniors or their caregivers?
The AGE-WELL National Impact Challenge is back for another run in 2020.
This national competition recognizes top startups and supports entrepreneurship in Canada's technology and aging sector.
Finalists will pitch their innovative technologies and services to a panel of expert judges. Regional competitions will be held in Halifax, Toronto and Whistler, British Columbia.
The winner at each competition will receive $20,000 in cash, plus in-kind prizes and a future opportunity to pitch to regional investors.
The deadline to submit an application is April 17, 2020 at 11:59 PM Eastern Standard Time. (From these applications, five finalists will be selected for each regional competition.)
"We're pleased to be running this competition once again and to be spotlighting top Canadian innovators whose products can positively impact older Canadians or their caregivers," says Dr. Alex Mihailidis, Scientific Co-Director and CEO of the AGE-WELL Network of Centres of Excellence (NCE).
As Canada's Technology and Aging Network, AGE-WELL brings together researchers, older adults, caregivers, partner organizations and future leaders to accelerate the delivery of technology-based solutions that make a meaningful difference in the lives of Canadians.
"AGE-WELL is propelling forward the technology and aging sector to ensure that technologies have an impact on people's lives, and generate social and economic benefits for Canadians," says Dr. Mihailidis.
Regional competitions are scheduled for Summer and Fall 2020. Please note that due to ongoing developments with COVID-19, the date and format for any events related to the competition are subject to change.
Sponsors of the competition are: BC Seniors Living Association, CARP, IBM, Impact Centre, Innovacorp, Innovation PEI, New Brunswick Innovation Foundation, Ontario Brain Institute, Spectrum Health Care, and YouAreUNLTD.
About AGE-WELL:
AGE-WELL NCE Inc. is Canada's Technology and Aging Network. The pan-Canadian network brings together researchers, older adults, caregivers, partner organizations and future leaders to accelerate the delivery of technology-based solutions that make a meaningful difference in the lives of Canadians. AGE-WELL researchers are producing technologies, services, policies and practices that improve quality of life for older adults and caregivers, and generate social and economic benefits for Canada. AGE-WELL is funded through the federal Networks of Centres of Excellence program. www.agewell-nce.ca.
SOURCE AGE-WELL Network of Centres of Excellence (NCE)
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
